Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)

v3.20.4
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Noncontrolling Interest
Total
Beginning balance, shares at Mar. 31, 2019 1,266,979        
Beginning balance, value at Mar. 31, 2019 $ 1,267 $ 108,076,275 $ (105,652,433) $ (126,031) $ 2,299,078
Issuances of common stock for cash under at the market program, shares 3,087        
Issuances of common stock for cash under at the market program, value $ 3 36,619 36,622
Loss on debt extinguishment 447,011 447,011
Issuance of common shares upon vesting of restricted stock units and net stock option exercise, shares 3,539        
Issuance of common shares upon vesting of restricted stock units and net stock option exercise, value $ 4 (23,775) (23,771)
Stock based compensation expense 326,536 326,536
Net loss (2,066,424) (860) (2,067,284)
Ending balance, shares at Jun. 30, 2019 1,273,605        
Ending balance, value at Jun. 30, 2019 $ 1,274 108,862,666 (107,718,857) (126,891) 1,018,192
Issuances of common stock for cash under at the market program, shares 59,340        
Issuances of common stock for cash under at the market program, value $ 60 386,552 386,612
Issuance of common shares upon vesting of restricted stock units and net stock option exercise, shares 3,236        
Issuance of common shares upon vesting of restricted stock units and net stock option exercise, value $ 4 (8,448) (8,445)
Issuance of common shares upon warrant exchanges, shares 1,078        
Issuance of common shares upon warrant exchanges, value $ 1 4,402 4,403
Stock based compensation expense 326,536 326,536
Net loss (1,705,037) (1,589) (1,706,626)
Ending balance, shares at Sep. 30, 2019 1,337,259        
Ending balance, value at Sep. 30, 2019 $ 1,339 109,571,708 (109,423,894) (128,480) 20,672
Issuance of common shares upon vesting of restricted stock units and net stock option exercise, shares 3,439        
Issuance of common shares upon vesting of restricted stock units and net stock option exercise, value $ 3 (6,772) (6,769)
Issuance of common shares upon warrant exchanges, shares 2,914        
Issuance of common shares upon warrant exchanges, value $ 3 (55,596) (55,593)
Par value of DTC roundup of shares following reverse split, shares 3,946        
Par value of DTC roundup of shares following reverse split, value $ 4 (4)
Proceeds from the issuance of common stock, net, shares 3,432,056        
Proceeds from the issuance of common stock, net, value $ 3,432 4,560,802 4,564,234
Stock based compensation expense 102,576 102,576
Net loss (819,581) (1,358) (820,939)
Ending balance, shares at Dec. 31, 2019 4,779,614        
Ending balance, value at Dec. 31, 2019 $ 4,781 114,172,714 (110,243,475) (129,838) 3,804,182
Beginning balance, shares at Mar. 31, 2020 9,366,873        
Beginning balance, value at Mar. 31, 2020 $ 9,368 121,426,563 (112,026,381) (132,124) 9,277,426
Issuances of common stock for cash under at the market program, shares 2,685,600        
Issuances of common stock for cash under at the market program, value $ 2,686 7,258,183 7,260,869
Issuance of common shares upon vesting of restricted stock units and net stock option exercise, shares 17,920        
Issuance of common shares upon vesting of restricted stock units and net stock option exercise, value $ 18 (24,269) (24,251)
Stock based compensation expense 84,207 84,207
Net loss (1,410,283) (863) (1,411,146)
Ending balance, shares at Jun. 30, 2020 12,070,393        
Ending balance, value at Jun. 30, 2020 $ 12,072 128,744,684 (113,436,664) (132,987) 15,187,105
Issuance of common shares upon vesting of restricted stock units and net stock option exercise, shares 17,920        
Issuance of common shares upon vesting of restricted stock units and net stock option exercise, value $ 17 (16,145) (16,128)
Stock based compensation expense 167,042   167,042
Net loss (1,770,564) (825) (1,771,389)
Ending balance, shares at Sep. 30, 2020 12,088,313        
Ending balance, value at Sep. 30, 2020 $ 12,089 128,895,581 (115,207,228) (133,812) 13,566,630
Issuance of common shares upon vesting of restricted stock units and net stock option exercise, shares 35,211        
Issuance of common shares upon vesting of restricted stock units and net stock option exercise, value $ 36 (66,048) (66,012)
Stock based compensation expense 377,958   377,958
Net loss (2,442,892) (1,498) (2,444,390)
Ending balance, shares at Dec. 31, 2020 12,123,524        
Ending balance, value at Dec. 31, 2020 $ 12,125 $ 129,207,491 $ (117,650,120) $ (135,310) $ 11,434,186